InvestorsHub Logo
Followers 57
Posts 5702
Boards Moderated 0
Alias Born 12/13/2004

Re: Whatsupp post# 7165

Friday, 11/09/2018 12:05:25 PM

Friday, November 09, 2018 12:05:25 PM

Post# of 21544
To be fair Anavex now has a phase 2b/3 trial enrolling in Australia, a Parkinson PDD phase 2 trial enrolling in Spain, and approval to enroll a Rett's trial in the US. PDD data will read out in Q2 2019,the same may be seen with the Rett trial, and there should be an interim analysis of the Alzheimer trial in Q3 or Q4 2019. And it has cash for 2 years.

I HOPE Anavex has success in all three trials.
I HOPE Neurotrope has success in all of its trials.

HOPE is all both of these companies have at this point. I hope they both succeed...that would be win/win for patients around the world. And wouldn't it be great if there was a synergy between the two treatment modalities! I hope so!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News